Category: Finance
-
New Funds Backing Global Health, Early-Stage Ventures
Three new funds are financing start-up companies creating solutions for health issues in less-developed countries and early-stage life science businesses.
-
Novartis, Gates Partner on Sickle Cell Gene Therapy
Global drug maker Novartis is collaborating with the Bill and Melinda Gates Foundation to find affordable gene therapies for sickle cell disease.
-
AI Cell Analysis Start-Up Raises $6M Seed Funds
A new enterprise using artificial intelligence to analyze individual cells for immune-related diagnostics and therapies is raising $6 million in seed funds.
-
Grant Funds Brain Disease Tissue Banks
An advocacy organization for neurodegenerative diseases and medical research foundation are sponsoring formation of a network to collect brain tissue samples.
-
$100M Challenge Seeks Carbon Removal Technologies
An XPrize challenge competition, sponsored by Elon Musk, is seeking new technologies that remove large quantities of carbon dioxide from the atmosphere.
-
New Venture Fund Backs Underserved, Academic Start-Ups
A new $300 million venture capital fund is underway that aims to support technology start-ups often left behind by larger mainstream investors.
-
Engineered Cell Therapy Company Issues $588M IPO
A company developing regenerative therapies with engineered stem cells for cancer and other diseases is raising $587.5 million in its initial public offering or IPO.
-
Cannabidiol Drug Maker Acquired in $7.2B Deal
A developer of treatments for rare neurological diseases derived from cannabis is being acquired by Jazz Pharmaceuticals in a $7.2 billion deal.
-
U.S. Supports Home Smartphone Covid-19 Test
The U.S. government is funding large-scale production of Covid-19 home test kits that send results to the user’s smartphone.
-
Investors Raise $1.85B for Biotech Start-Ups
A venture capital company investing in life science and health care businesses raised $1.85 billion to finance biotechnology start-ups.